Rossi, Giulio
Azienda Ospedaliero - Universitaria di Modena,
Italy
2025 Rank: 355266
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 473 out of 25326 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 355266 | 404438 |
| Total Cites | 341 | 367 |
| H-index | 8 | 8 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 82 | 82 |
| Number of Single+First+Last Authored Papers | 108 | 108 |
| Total Cites to Single+First+Last Authored Papers | 142 | 144 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 307 | 324 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.13 |
| Self-Citation Percentage |
7.08%
|
|
Rossi, Giulio
Pathology Unit,
Italy
2022 Rank: 220164
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 390 out of 23010 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 220164 | 248306 |
| Total Cites | 437 | 493 |
| H-index | 10 | 10 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 105 | 111 |
| Number of Single+First+Last Authored Papers | 108 | 108 |
| Total Cites to Single+First+Last Authored Papers | 174 | 184 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 386 | 424 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.16 |
| Self-Citation Percentage |
11.36%
|
|
Rossi, Giulio
Azienda Ospedaliera di Ravenna,
Italy
2021 Rank: 211218
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 397 out of 22656 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 211218 | 237752 |
| Total Cites | 667 | 753 |
| H-index | 13 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 161 | 166 |
| Number of Single+First+Last Authored Papers | 111 | 111 |
| Total Cites to Single+First+Last Authored Papers | 263 | 273 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 589 | 650 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.16 |
| Self-Citation Percentage |
11.42%
|
|
Rossi, Giulio
Ospedale S. Maria delle Croci,
Italy
2020 Rank: 168313
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 308 out of 19713 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 168313 | 180746 |
| Total Cites | 553 | 622 |
| H-index | 11 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 130 | 134 |
| Number of Single+First+Last Authored Papers | 108 | 108 |
| Total Cites to Single+First+Last Authored Papers | 236 | 243 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 491 | 539 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
11.09%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.